Putting the award page together from the records…
Putting the award page together from the records…
Paratek Pharmaceuticals, Inc received this contract from Barda - Aspr / Daappo / Barda Dcma, Office of Assistant Secretary for Preparedness and Response: $77.11M obligated so far for drugs and biologicals. It runs to 2029-12-17.
Key facts · data as of Oct 23, 2026
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 23, 2026.
Cite this page: SpendQuery, Award 75A50120C00001, data as of Oct 23, 2026, https://spendquery.com/award?id=CONT_AWD_75A50120C00001_7505_-NONE-_-NONE-
Paratek Pharmaceuticals, Inc: all federal awards · Department of Health and Human Services: spending · Barda - Aspr / Daappo / Barda Dcma: what it buys
ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
10 actions since 2022-12-15. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-02-20 | P00013 | Administrative change | $0 | ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION |
| 2026-02-19 | P00012 | Supplemental agreement (work within scope) | $17.47M | ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION |
| 2025-03-31 | P00011 | Supplemental agreement (work within scope) | $4.96M | ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION |
| 2025-02-27 | P00010 | Supplemental agreement (work within scope) | $0 | ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION |
| 2024-12-11 | P00009 | Change order | $0 | ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION |
| 2024-06-17 | P00008 | Supplemental agreement (work within scope) | $0 | ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION |
| 2024-02-06 | P00007 | Option exercised | $17.47M | ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION |
| 2023-11-29 | P00006 | Supplemental agreement (work within scope) | $808.0K | ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION |
| 2023-06-28 | P00005 | Supplemental agreement (work within scope) | $0 | ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION |
| 2022-12-15 | P00004 | Change order | $36.40M | ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-23). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗